Patients currently enrolled in the study can continue to receive treatment, but no new patients can be enrolled. … [Read more...]
Drug Delivery West (5/23/22 – 5/24)
Senate Committee Releases Draft User Fee Bill as House Votes to Send Its Version to the Floor
The House Energy and Commerce Committee voted unanimously Wednesday to move its version of a bill to reauthorize the FDA’s prescription drug, generic drug, biosimilar and medical device user fee programs to the full House floor, one day after the Senate’s Health, Education, Labor and Pensions (HELP) Committee released its draft of the same legislation. … [Read more...]
Demystifying Machine Learning: Why Transparency Will Lead to Trust
Authored and contributed to PharmaLeaders by Michelle Marlborough, Chief Product Officer, AiCure, LLC Machine learning (ML) innovation for clinical research holds great promise for improving drug development and patient care. But, like with all new technology, increasing prevalence can be accompanied by growing skepticism. Pharmaceutical sponsors and clinicians are … [Read more...]
Pharma join together to achieve new standards in digital and patient innovation for clinical transformation
On May 17th, 500+ of pharma’s clinical innovation will come together for the home of clinical collaboration, Reuters Events: Pharma Clinical 2022, to set new standards in digital and patient innovation for clinical transformation. The catalyst for this has been the accelerated technological adoption in clinical trials, but a general feeling still that enough isn’t being done … [Read more...]